Boston, MANCT06674109Now EnrollingIRB Ready

Gout and Hyperuricemia Clinical Trial in Boston, MA

Access cutting-edge gout and hyperuricemia treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts General Hospital

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access gout and hyperuricemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gout and hyperuricemia treatment provided free

Apply for This Boston Location

Check if you qualify for this gout and hyperuricemia clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Gout and Hyperuricemia Study in Boston

SAVE-Care (Sodium Glucose Cotransporter-2 inhibitors \[SGLT2i\] As Novel Gout Care) Trial is a double-blind randomized placebo-controlled trial (RCT) designed to assess the effect of empagliflozin on serum urate \[SU\] levels of gout patients, as well as levels of highly-sensitivity C-reactive protein \[hsCRP\] and interleukin 6 \[IL-6\], and estimate gout flares over 3 months, in order to develop a full-scale RCT of clinical endpoints to directly inform gout care guidelines.

Sponsor: Massachusetts General Hospital

Who Can Participate

Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Provision of signed and dated informed consent form.
Fulfilling American College of Rheumatology \[ACR\]/European Alliance of Associations for Rheumatology \[EULAR\] gout criteria
1+ gout flares in last 12 months
Serum urate level ≥ 6mg/dl
Males and females; Age 18-80
Willingness to adhere to the study intervention procedures.

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:
Estimated Glomerular Filtration Rate \[eGFR\] \<20ml/min
Colchicine or nonsteroidal anti-inflammatory drug \[NSAID\] prophylaxis
active cardiovascular disease \[CVD\], type-1 diabetes
pregnant and lactating women
Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation. \[History of ketoacidosis, end-stage or decompensated liver disease, active cancer\]
Use of anti-obesity drugs
Basal-bolus or multiple daily injection insulin regimens, or loop diuretics

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06674109) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gout and Hyperuricemia Treatment Options in Boston, MA

If you're searching for gout and hyperuricemia treatment options in Boston, MA, this clinical trial (NCT06674109) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gout and hyperuricemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gout and hyperuricemia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Boston, MA

See all heart attack clinical trials recruiting in Boston — not just this study.

Browse Heart Attack Trials in Boston →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Embolism TrialsGout TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA